Comparative evaluation of the nanosphere verigene RV+ assay and the simplexa flu A/B & RSV kit for detection of influenza and respiratory syncytial viruses

Abstract

Using retrospective (n = 200) and prospective (n = 150) nasopharyngeal specimens, we evaluated the Nanosphere Verigene RV+ and the Focus Diagnostics Simplexa Flu A/B & RSV tests. Overall, RV+ demonstrated sensitivities and specificities of 96.6% and 100% for influenza A virus, 100% and 99.7% for influenza B virus, and 100% and 100% for respiratory syncytial virus (RSV), while the Simplexa test sensitivities and specificities were 82.8 and 99.7%, 76.2 and 100%, and 94.6 and 100%, respectively. Copyright © 2013, American Society for Microbiology. All Rights Reserved.